The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Triple-Negative Breast Carcinoma
Interventions: DRUG: Bexarotene|DRUG: Capecitabine
Sponsor: National Cancer Centre, Singapore
Collaborators: National Medical Research Council (NMRC), Singapore